| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
601.55 | 601.55 | 0 | 722.04 | 626.46 |
|
Cost of Revenue
|
-152.05 | -152.05 | -244.17 | -2,099.90 | -1,984.98 |
|
Gross Profit
|
449.50 | 449.50 | -244.17 | -1,377.86 | -1,358.52 |
| Selling, General and Administrative Expenses
|
-8,809.82 | -8,809.82 | -9,268.99 | -8,966.12 | -10,160.09 |
| Other Income/Expense, Operating
|
420 | 420 | 3.60 | 14.42 | 13.96 |
|
Operating Income/Expenses
|
-8,389.82 | -8,389.82 | -9,265.39 | -8,951.70 | -10,146.13 |
|
Total Operating Profit/Loss
|
-7,940.32 | -7,940.32 | -9,509.57 | -10,329.56 | -11,504.65 |
| Total Net Finance Income/Expense
|
-167,649.68 | -167,649.68 | -5,931.40 | -2,594.59 | -115.81 |
| Net Investment Income
|
-25.75 | -25.75 | -12.73 | 6,561.30 | 785.43 |
|
Rental Income
|
0 | 0 | 2.64 | 0 | 4.99 |
| Irregular Income/Expenses
|
35 | 35 | -9,506.52 | -3,531.47 | 0 |
|
Non-Operating Income/Expenses, Total
|
-167,640.42 | -167,640.42 | -15,448.02 | 435.24 | 674.61 |
|
Pretax Income
|
-175,580.74 | -175,580.74 | -24,957.59 | -9,894.32 | -10,830.04 |
| Provision for Income Tax
|
134.47 | 134.47 | 264.57 | 194.40 | 544.60 |
|
Net Income from Continuing Operations
|
-175,446.27 | -175,446.27 | -24,693.01 | -9,699.92 | -10,285.44 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-175,446.27 | -175,446.27 | -24,693.01 | -9,699.92 | -10,285.44 |
|
Net Income after Non-Controlling/Minority Interests
|
-175,446.27 | -175,446.27 | -24,693.01 | -9,699.92 | -10,285.44 |
|
Net Income Available to Common Stockholders
|
-175,446.27 | -175,446.27 | -24,693.01 | -9,699.92 | -10,285.44 |
|
Diluted Net Income Available to Common Stockholders
|
-175,446.27 | -175,446.27 | -24,693.01 | -9,699.92 | -10,285.44 |
| Basic EPS
|
-0.12 | -0.12 | -0.13 | -0.05 | -0.06 |
| Diluted EPS
|
-0.12 | -0.12 | -0.13 | -0.05 | -0.06 |
|
Basic Weighted Average Shares Outstanding
|
1,504,748.76 | 1,504,748.76 | 188,731.31 | 185,755.36 | 193,591.63 |
|
Diluted Weighted Average Shares Outstanding
|
1,504,748.76 | 1,504,748.76 | 188,731.31 | 185,755.36 | 193,591.63 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-7,936.22 | -7,936.22 | -19,031.95 | -7,305.09 | -10,718.31 |
|
EBITDA
|
-7,561.28 | -7,561.28 | -18,561.92 | -6,782.20 | -10,203.92 |
|
Normalized EBITDA
|
-7,740.30 | -7,740.30 | -8,932.72 | -9,952.72 | -10,492.25 |
|
Normalized Income
|
-175,625.15 | -175,625.15 | -15,165.90 | -12,808.15 | -10,559.27 |
|
Total Unusual Items
|
-179.02 | -179.02 | 9,629.20 | -3,170.53 | -288.33 |
|
Total Unusual Items Excluding Goodwill
|
-179.02 | -179.02 | 9,629.20 | -3,170.53 | -288.33 |
3/31/2023 - 10/21/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade